PortViewPortView
Mesa Laboratories logo

Mesa Laboratories (MLAB) Stock Analysis

NASDAQHealthcareMedical - Specialties

$129.11+2.90%
1-year price historyRange $59.53 – $129.37
52-week range$129.11
$58.83$129.95

What Mesa Laboratories does

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Key metrics

Market cap
$722.48M
P/E (TTM)
13.03
EPS (TTM)
$9.91
Beta
0.93
Dividend yield
0.50%
Revenue / share
$44.14
50-day avg
$105.52
200-day avg
$93.73
52-week high
$129.95
52-week low
$58.83
CEO
Siddhartha C. Kadia

ETFs linked to MLAB

Broad-market and Healthcare sector ETFs an investor holding Mesa Laboratories is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MLAB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MLAB in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Mesa Laboratories?
Mesa Laboratories trades under the ticker MLAB on NASDAQ.
Which exchange is MLAB listed on?
MLAB is listed on NASDAQ.
What sector does Mesa Laboratories operate in?
Mesa Laboratories is classified in the Healthcare sector (Medical - Specialties industry).
How can PortView help analyze MLAB in a portfolio?
PortView shows MLAB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.